MENU
+Compare
XNCR
Stock ticker: NASDAQ
AS OF
Apr 23, 04:59 PM (EDT)
Price
$10.86
Change
+$0.20 (+1.88%)
Capitalization
765.92M

XNCR Xencor Forecast, Technical & Fundamental Analysis

Xencor Inc a clinical-stage biopharmaceutical company focused on discovering and developing engineered antibody therapeutics to treat patients with cancer and autoimmune diseases... Show more

Industry: #Biotechnology
XNCR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for XNCR with price predictions
Apr 22, 2025

XNCR's MACD Histogram just turned positive

The Moving Average Convergence Divergence (MACD) for XNCR turned positive on April 14, 2025. Looking at past instances where XNCR's MACD turned positive, the stock continued to rise in of 57 cases over the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where XNCR's RSI Indicator exited the oversold zone, of 38 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Momentum Indicator moved above the 0 level on April 17, 2025. You may want to consider a long position or call options on XNCR as a result. In of 79 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where XNCR advanced for three days, in of 255 cases, the price rose further within the following month. The odds of a continued upward trend are .

XNCR may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 3 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where XNCR declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for XNCR entered a downward trend on April 21, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.107) is normal, around the industry mean (13.887). P/E Ratio (0.000) is within average values for comparable stocks, (63.180). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.782). Dividend Yield (0.000) settles around the average of (0.025) among similar stocks. P/S Ratio (6.270) is also within normal values, averaging (251.479).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. XNCR’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. XNCR’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

View a ticker or compare two or three
XNCR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

XNCR is expected to report earnings to -62 cents per share on May 08

Xencor XNCR Stock Earnings Reports
Q1'25
Est.
$-0.62
Q4'24
Beat
by $0.19
Q3'24
Beat
by $0.27
Q2'24
Missed
by $0.25
Q1'24
Missed
by $0.30
The last earnings report on February 28 showed earnings per share of -62 cents, beating the estimate of -81 cents. With 1.27M shares outstanding, the current market capitalization sits at 765.92M.
A.I. Advisor
published General Information

General Information

a developer of therapeutics to treat autoimmune and allergic diseases, cancer and other conditions

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
465 North Halstead Street
Phone
+1 626 305-5900
Employees
256
Web
https://www.xencor.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
BARDX7.930.12
+1.54%
iShares Developed Real Estate Idx Inv A
TIGCX19.440.22
+1.14%
Thornburg International Growth C
FTADX48.66N/A
N/A
Fidelity Advisor International Discv M
CSCRX23.36N/A
N/A
Columbia Small Cap Growth Inst2
STRAX28.75N/A
N/A
Sterling Capital Behav Lg Cp Val Eq R6

XNCR and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, XNCR has been loosely correlated with ERAS. These tickers have moved in lockstep 53% of the time. This A.I.-generated data suggests there is some statistical probability that if XNCR jumps, then ERAS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To XNCR
1D Price
Change %
XNCR100%
+0.47%
ERAS - XNCR
53%
Loosely correlated
+11.29%
VCYT - XNCR
52%
Loosely correlated
+1.73%
CRNX - XNCR
52%
Loosely correlated
+3.71%
RCKT - XNCR
51%
Loosely correlated
-2.79%
ACLX - XNCR
49%
Loosely correlated
+3.59%
More